Share Prices & Company Research

Market News

07 Apr 2021 | 15:32

EMA finds potential link between AstraZeneca Covid-19 vaccine and blood clots

(Sharecast News) - The European Medicines Agency said on Wednesday it had found a potential link between AstraZeneca's Covid-19 vaccine and blood clots in adults who had received the shot.

The EMA said it had taken into consideration all available evidence, according to Reuters.

"One plausible explanation for the combination of blood clots and low blood platelets is an immune response, leading to a condition similar to one seen sometimes in patients treated with heparin," the watchdog said in a statement.

The regulator had backed the vaccine up until the prior week, saying there was no evidence of risk of blood clotting in general.

The news was a blow for the pharma company which is one of the most popular choices when it comes to acquiring shots to treat the illness.

EMA's safety committee, which was assessing the shot, had requested for more studies and changes to the current ones to get more information.
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 30th April 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.